« Pilot study of flesinoxan, a 5-HT1A agonist, in major depression: Effects on sleep REM latency and body temperature », Human Psychopharmacology: Clinical and Experimental, vol. 8, no 4, , p. 279–283 (DOI10.1002/hup.470080407, lire en ligne [archive du ])
doi.org
dx.doi.org
« Serotonin 1A receptors in human and monkey prefrontal cortex are mainly expressed in pyramidal neurons and in a GABAergic interneuron subpopulation: implications for schizophrenia and its treatment », Journal of Neurochemistry, vol. 107, no 2, , p. 488–96 (PMID18761712, DOI10.1111/j.1471-4159.2008.05649.x)
« Pharmacological studies of 8-OH-DPAT-induced pupillary dilation in anesthetized rats », European Journal of Pharmacology, vol. 489, no 3, , p. 207–13 (PMID15087245, DOI10.1016/j.ejphar.2004.03.007)
« 8-OH-DPAT-induced mydriasis in mice: a pharmacological characterisation », European Journal of Pharmacology, vol. 317, no 1, , p. 21–8 (PMID8982715, DOI10.1016/S0014-2999(96)00693-0)
« Buspirone, but not sumatriptan, induces miosis in humans: relevance for a serotoninergic pupil control », Clinical Pharmacology and Therapeutics, vol. 57, no 3, , p. 349–55 (PMID7697953, DOI10.1016/0009-9236(95)90161-2)
« Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression », European Journal of Pharmacology, vol. 134, no 3, , p. 265–74 (PMID2883013, DOI10.1016/0014-2999(87)90357-8)
« Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain », European Journal of Pharmacology, vol. 493, nos 1–3, , p. 75–83 (PMID15189766, DOI10.1016/j.ejphar.2004.04.028)
« 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis », European Journal of Pharmacology, vol. 526, nos 1–3, , p. 125–39 (PMID16310183, DOI10.1016/j.ejphar.2005.09.065)
« Behavioural pharmacology of the serenic, eltoprazine », Drug Metabolism and Drug Interactions, vol. 8, nos 1–2, , p. 31–83 (PMID2091890, DOI10.1515/DMDI.1990.8.1-2.31)
« Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders », Neuropsychopharmacology, vol. 30, no 4, , p. 669–82 (PMID15688093, DOI10.1038/sj.npp.1300610)
« A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy") », Neuroscience, vol. 146, no 2, , p. 509–14 (PMID17383105, DOI10.1016/j.neuroscience.2007.02.032)
« 8-OH-DPAT and male rat sexual behavior: partial blockade by noradrenergic lesion and sexual exhaustion », Pharmacology, Biochemistry, and Behavior, vol. 56, no 1, , p. 111–6 (PMID8981617, DOI10.1016/S0091-3057(96)00165-7)
« 5-HT1A receptor agonists prevent in rats the yawning and penile erections induced by direct dopamine agonists », Psychopharmacology, vol. 108, nos 1–2, , p. 47–50 (PMID1357709, DOI10.1007/BF02245284)
« Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors », European Journal of Pharmacology, vol. 321, no 3, , R11-3 (PMID9085055, DOI10.1016/S0014-2999(97)00050-2)
« 8-Hydroxy-2-(di-n-propylamino)-tetralin inhibits food intake in fasted rats by an action at 5-HT1A receptors », Methods and Findings in Experimental and Clinical Pharmacology, vol. 29, no 4, , p. 269–72 (PMID17609739, DOI10.1358/mf.2007.29.4.1075362)
« Dose-dependent effects of the 5-HT1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat », Journal of Sleep Research, vol. 1, no 3, , p. 169–175 (PMID10607047, DOI10.1111/j.1365-2869.1992.tb00033.x)
« Pilot study of flesinoxan, a 5-HT1A agonist, in major depression: Effects on sleep REM latency and body temperature », Human Psychopharmacology: Clinical and Experimental, vol. 8, no 4, , p. 279–283 (DOI10.1002/hup.470080407, lire en ligne [archive du ])
« A comparison of the oxytocin and vasopressin responses to the 5-HT1A agonist and potential anxiolytic drug alnespirone (S-20499) », Pharmacology, Biochemistry, and Behavior, vol. 60, no 3, , p. 677–83 (PMID9678651, DOI10.1016/S0091-3057(98)00025-2)
« Differential effects of serotonin (5-HT1A and 5-HT2) agonists and antagonists on renin and corticosterone secretion », Neuroendocrinology, vol. 45, no 4, , p. 305–10 (PMID2952898, DOI10.1159/000124754)
« Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation », European Journal of Pharmacology, vol. 137, no 1, , p. 1–8 (PMID2956114, DOI10.1016/0014-2999(87)90175-0)
« Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study », European Neuropsychopharmacology, vol. 14, no 2, , p. 151–5 (PMID15013031, DOI10.1016/S0924-977X(03)00108-1)
« Localization of 5-HT1A receptors in the living human brain using [carbonyl-11C]WAY-100635: PET with anatomic standardization technique », Journal of Nuclear Medicine, vol. 40, no 1, , p. 102–9 (PMID9935065)
« Serotonin 1A receptors in human and monkey prefrontal cortex are mainly expressed in pyramidal neurons and in a GABAergic interneuron subpopulation: implications for schizophrenia and its treatment », Journal of Neurochemistry, vol. 107, no 2, , p. 488–96 (PMID18761712, DOI10.1111/j.1471-4159.2008.05649.x)
« Central 5-hydroxytryptamine (5-HT) receptors in blood pressure regulation », Therapie, vol. 46, no 6, , p. 421–9 (PMID1819150)
« Pharmacological studies of 8-OH-DPAT-induced pupillary dilation in anesthetized rats », European Journal of Pharmacology, vol. 489, no 3, , p. 207–13 (PMID15087245, DOI10.1016/j.ejphar.2004.03.007)
« 8-OH-DPAT-induced mydriasis in mice: a pharmacological characterisation », European Journal of Pharmacology, vol. 317, no 1, , p. 21–8 (PMID8982715, DOI10.1016/S0014-2999(96)00693-0)
« Buspirone, but not sumatriptan, induces miosis in humans: relevance for a serotoninergic pupil control », Clinical Pharmacology and Therapeutics, vol. 57, no 3, , p. 349–55 (PMID7697953, DOI10.1016/0009-9236(95)90161-2)
« Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression », European Journal of Pharmacology, vol. 134, no 3, , p. 265–74 (PMID2883013, DOI10.1016/0014-2999(87)90357-8)
« Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain », European Journal of Pharmacology, vol. 493, nos 1–3, , p. 75–83 (PMID15189766, DOI10.1016/j.ejphar.2004.04.028)
« 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis », European Journal of Pharmacology, vol. 526, nos 1–3, , p. 125–39 (PMID16310183, DOI10.1016/j.ejphar.2005.09.065)
« Behavioural pharmacology of the serenic, eltoprazine », Drug Metabolism and Drug Interactions, vol. 8, nos 1–2, , p. 31–83 (PMID2091890, DOI10.1515/DMDI.1990.8.1-2.31)
« Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders », Neuropsychopharmacology, vol. 30, no 4, , p. 669–82 (PMID15688093, DOI10.1038/sj.npp.1300610)
« A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy") », Neuroscience, vol. 146, no 2, , p. 509–14 (PMID17383105, DOI10.1016/j.neuroscience.2007.02.032)
« 8-OH-DPAT and male rat sexual behavior: partial blockade by noradrenergic lesion and sexual exhaustion », Pharmacology, Biochemistry, and Behavior, vol. 56, no 1, , p. 111–6 (PMID8981617, DOI10.1016/S0091-3057(96)00165-7)
« 5-HT1A receptor agonists prevent in rats the yawning and penile erections induced by direct dopamine agonists », Psychopharmacology, vol. 108, nos 1–2, , p. 47–50 (PMID1357709, DOI10.1007/BF02245284)
« Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors », European Journal of Pharmacology, vol. 321, no 3, , R11-3 (PMID9085055, DOI10.1016/S0014-2999(97)00050-2)
« 8-Hydroxy-2-(di-n-propylamino)-tetralin inhibits food intake in fasted rats by an action at 5-HT1A receptors », Methods and Findings in Experimental and Clinical Pharmacology, vol. 29, no 4, , p. 269–72 (PMID17609739, DOI10.1358/mf.2007.29.4.1075362)
« Dose-dependent effects of the 5-HT1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat », Journal of Sleep Research, vol. 1, no 3, , p. 169–175 (PMID10607047, DOI10.1111/j.1365-2869.1992.tb00033.x)
« A comparison of the oxytocin and vasopressin responses to the 5-HT1A agonist and potential anxiolytic drug alnespirone (S-20499) », Pharmacology, Biochemistry, and Behavior, vol. 60, no 3, , p. 677–83 (PMID9678651, DOI10.1016/S0091-3057(98)00025-2)
« Differential effects of serotonin (5-HT1A and 5-HT2) agonists and antagonists on renin and corticosterone secretion », Neuroendocrinology, vol. 45, no 4, , p. 305–10 (PMID2952898, DOI10.1159/000124754)
« Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation », European Journal of Pharmacology, vol. 137, no 1, , p. 1–8 (PMID2956114, DOI10.1016/0014-2999(87)90175-0)
« Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study », European Neuropsychopharmacology, vol. 14, no 2, , p. 151–5 (PMID15013031, DOI10.1016/S0924-977X(03)00108-1)
« Pilot study of flesinoxan, a 5-HT1A agonist, in major depression: Effects on sleep REM latency and body temperature », Human Psychopharmacology: Clinical and Experimental, vol. 8, no 4, , p. 279–283 (DOI10.1002/hup.470080407, lire en ligne [archive du ])